Atiprimod triggered apoptotic cell death via acting on PERK/eIF2α/ATF4/CHOP and STAT3/NF-ΚB axis in MDA-MB-231 and
Ajda Coker-Gurkan1, Esin Can2, Semanur Sahin2
1Department of Molecular Biology and Genetics, Faculty of Engineering and Natural Sciences, Biruni University, Topkapı Campus, 34010, Istanbul, Turkey. ajdaaacoker@gmail.com.
Purpose:
The constitutive activation of STAT3 through receptor tyrosine kinases triggered breast cancer cell growth and invasion-metastasis. Atiprimod impacts anti-proliferative, anti-carcinogenic effects in hepatocellular carcinoma, lymphoma, multiple myeloma via hindering the biological activity of STAT3. Dose-dependent atiprimod evokes first autophagy as a survival mechanism and then apoptosis due to prolonged ER stress in pituitary adenoma cells. The therapeutic efficiency and mechanistic action of atiprimod in breast cancer cells have not been investigated yet. Thus, we aimed to modulate the pivotal role of ER stress in atiprimod-triggered apoptosis in MDA-MB-231 and MDA-MB-468 breast cancer cells.
Results:
Dose- and time-dependent atiprimod treatment inhibits cell viability and colony formation in MDA-MB-468 and MDA-MB-231 breast cancer cells. A moderate dose of atiprimod (2 μM) inhibited STAT3 phosphorylation at Tyr705 residue and also suppressed the total expression level of p65. In addition, nuclear localization of STAT1, 3, and NF-κB was prevented by atiprimod exposure in MDA-MB-231 and MDA-MB-468 cells. Atiprimod evokes PERK, BiP, ATF-4, CHOP upregulation, and PERK (Thr980), eIF2α (Ser51) phosphorylation's. However, atiprimod suppressed IRE1α-mediated Atg-3, 5, 7, 12 protein expressions and no alteration was observed on Beclin-1, p62 expression levels. PERK/eIF2α/ATF4/CHOP axis pivotal role in atiprimod-mediated G1/S arrest and apoptosis via Bak, Bax, Bim, and PUMA upregulation in MDA-MB-468 cells. Moreover, atiprimod renders MDA-MB-231 more vulnerable to type I programmed cell death by plasmid-mediated increased STAT3 expression.
Conclusion:
Atiprimod induced prolonged ER stress-mediated apoptosis via both activating PERK/eIF2α/ATF4/CHOP axis and suppressing STAT3/NF-κB transcription factors nuclear migration in TBNC cells.
Insights
Atiprimod triggers breast cancer cell death by inducing endoplasmic reticulum stress and inhibiting STAT3/NF-κB pathways. This study reveals its potential as a novel therapeutic agent for triple-negative breast cancer (TBNC).
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Constitutive activation of STAT3 drives breast cancer growth and metastasis.
- Atiprimod exhibits anti-cancer effects in various cancers by inhibiting STAT3.
- The role of atiprimod in breast cancer, particularly its mechanism involving ER stress, remains unexplored.
Purpose of the Study:
- To investigate the therapeutic efficiency and mechanistic action of atiprimod in MDA-MB-231 and MDA-MB-468 breast cancer cells.
- To elucidate the role of endoplasmic reticulum (ER) stress in atiprimod-induced apoptosis.
Main Methods:
- Dose- and time-dependent treatment of breast cancer cells (MDA-MB-468, MDA-MB-231) with atiprimod.
- Assessment of cell viability, colony formation, and protein expression levels (STAT3, p65, PERK, BiP, ATF-4, CHOP, etc.).
- Analysis of protein phosphorylation and nuclear localization of transcription factors (STAT1, STAT3, NF-κB).
Main Results:
- Atiprimod significantly inhibited cell viability and colony formation in both cell lines.
- Atiprimod suppressed STAT3 phosphorylation and p65 expression, preventing nuclear translocation of STAT1, STAT3, and NF-κB.
- Atiprimod induced ER stress by upregulating PERK, BiP, ATF-4, CHOP, and activating the PERK/eIF2α/ATF4/CHOP axis, leading to G1/S arrest and apoptosis.
Conclusions:
- Atiprimod induces apoptosis in triple-negative breast cancer (TBNC) cells through prolonged ER stress.
- The mechanism involves activation of the PERK/eIF2α/ATF4/CHOP pathway and suppression of STAT3/NF-κB nuclear migration.
- Atiprimod demonstrates potential as a therapeutic agent for TBNC by modulating ER stress and key signaling pathways.
More Related Videos
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
15:53Cell Death Associated with Abnormal Mitosis Observed by Confocal Imaging in Live Cancer Cells
Published on: August 21, 2013
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Apoptosis
PI3K/mTOR/AKT Signaling Pathway
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
